Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
insulin glargine product
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A10AE04
|
| gptkbp:biosimilar |
gptkb:Lantus
|
| gptkbp:brand |
gptkb:insulin
|
| gptkbp:contains |
gptkb:insulin
|
| gptkbp:form |
cartridge
|
| https://www.w3.org/2000/01/rdf-schema#label |
Basaglar Cartridge
|
| gptkbp:indication |
gptkb:type_2_diabetes_mellitus
gptkb:type_1_diabetes_mellitus |
| gptkbp:manufacturer |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:powers |
100 units/mL
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:usedFor |
insulin pen device
|
| gptkbp:bfsParent |
gptkb:Basaglar
|
| gptkbp:bfsLayer |
7
|